Citation: G. Vandenberghe et al., THE SOMATOTROPIC AXIS IN CRITICAL ILLNESS - EFFECTS OF GROWTH-HORMONESECRETAGOGUES, Growth hormone & IGF research, 8, 1998, pp. 153-155
Citation: J. Ross et T. Ryoke, EFFECTS OF GROWTH-HORMONE AND INSULIN-LIKE-GROWTH-FACTOR-I IN EXPERIMENTAL HEART-FAILURE, Growth hormone & IGF research, 8, 1998, pp. 159-161
Citation: My. Donath et al., INSULIN-LIKE-GROWTH-FACTOR-I AND CARDIAC-PERFORMANCE IN HEART-FAILURE, Growth hormone & IGF research, 8, 1998, pp. 167-170
Citation: Ch. Bergh, GROWTH-HORMONE AS ADDITIONAL TREATMENT FOR PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE - A REVIEW, Growth hormone & IGF research, 8, 1998, pp. 171-173
Citation: Sm. Shalet et Rg. Rosenfeld, GROWTH-HORMONE REPLACEMENT THERAPY DURING TRANSITION OF PATIENTS WITHCHILDHOOD-ONSET GROWTH-HORMONE DEFICIENCY INTO ADULTHOOD - WHAT ARE THE ISSUES, Growth hormone & IGF research, 8, 1998, pp. 177-184
Citation: 24TH INTERNATIONAL-SYMPOSIUM ON GH AND GROWTH-FACTORS IN ENDOCRINOLOGY AND METABOLISM - PROCEEDINGS OF A MEETING HELD IN ANTWERP, OCTOBER 1997 - ABSTRACTS, Growth hormone & IGF research, 8, 1998, pp. 187-206
Authors:
BUTENANDT O
JOCHAM A
SCHWARZ HP
SPERLICH M
TSCHOP M
Citation: O. Butenandt et al., CHILDHOOD-ONSET OF GH DEFICIENCY - REASSESSMENT OF GH STATUS AND EFFECTS OF SUBSTITUTION, Growth hormone & IGF research, 8, 1998, pp. 9-13
Authors:
JUUL A
VAHL N
JORGENSEN JO
CHRISTIANSEN JS
SNEPPEN SB
FELDTRASMUSSEN U
SKAKKEBAEK NE
Citation: A. Juul et al., CONSEQUENCES OF STOPPING GROWTH-HORMONE (GH) THERAPY IN YOUNG GH DEFICIENT PATIENTS WITH CHILDHOOD-ONSET DISEASE, Growth hormone & IGF research, 8, 1998, pp. 15-19
Citation: Ml. Hartman, THE GROWTH-HORMONE-RESEARCH-SOCIETY CONSENSUS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ADULT GH DEFICIENCY, Growth hormone & IGF research, 8, 1998, pp. 25-29
Citation: H. Vierhapper, ROLE, SENSITIVITY AND VALIDITY OF GH STIMULATION TESTS IN THE DIAGNOSIS OF GROWTH-HORMONE DEFICIENCY IN ADULTS, Growth hormone & IGF research, 8, 1998, pp. 37-40
Citation: Joi. Jorgensen, HARD END-POINTS FOR GH REPLACEMENT THERAPY - REPORT FROM AN INTERACTIVE DISCUSSION OF BONE STATUS AND CARDIOVASCULAR FUNCTION IN GH-DEFICIENT ADULTS, Growth hormone & IGF research, 8, 1998, pp. 63-67
Authors:
BRIXEN K
HANSEN TB
ERIKSEN EF
MOSEKILDE L
Citation: K. Brixen et al., DOES GROWTH-HORMONE THERAPY IN ADULT PATIENTS WITH GROWTH-HORMONE DEFICIENCY PROTECT AGAINST BONE LOSS, Growth hormone & IGF research, 8, 1998, pp. 81-86
Authors:
WUSTER C
HARLE U
REHN U
MULLER C
KNAUF K
KOPPLER D
SCHWABE C
ZIEGLER R
Citation: C. Wuster et al., BENEFITS OF GROWTH-HORMONE TREATMENT ON BONE METABOLISM, BONE-DENSITYAND BONE STRENGTH IN GROWTH-HORMONE DEFICIENCY AND OSTEOPOROSIS, Growth hormone & IGF research, 8, 1998, pp. 87-94
Citation: C. Laurino et R. Cordera, ROLE OF IRS-1 AND SHC ACTIVATION IN 3T3-L1 FIBROBLASTS DIFFERENTIATION, Growth hormone & IGF research, 8(5), 1998, pp. 363-367